Related Experiment Video
Updated: Feb 6, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Thyroid stimulating hormone elevation as a predictor of long-term mortality in patients with acute myocardial
Suk Min Seo1, Yoon-Seok Koh1, Hun-Jun Park1
1Department of Internal Medicine, Cardiovascular Center and Cardiology Division, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
Insights
Elevated thyroid-stimulating hormone (TSH) in acute myocardial infarction (AMI) patients is linked to increased mortality. This finding highlights TSH elevation as a significant predictor of worse clinical outcomes in AMI survivors.
Area of Science:
- Cardiology
- Endocrinology
- Clinical Outcomes Research
Background:
- Hypothyroidism is linked to hyperlipidemia, endothelial dysfunction, and atherosclerosis.
- Thyroid-stimulating hormone (TSH) elevation is a key indicator for these conditions.
- Limited research exists on TSH elevation's impact on long-term outcomes in acute myocardial infarction (AMI) patients.
Purpose of the Study:
- To investigate the association between TSH elevation and long-term clinical outcomes, specifically mortality, in patients with AMI.
- To determine if hypothyroidism is associated with higher mortality rates in patients following an acute myocardial infarction.
Main Methods:
- Analysis of 1977 AMI patients who underwent percutaneous coronary intervention (PCI) with drug-eluting stents, excluding those with hyperthyroidism or central hypothyroidism.
- Patients were categorized into euthyroid (normal TSH, normal free thyroxine) and hypothyroidism (elevated TSH, normal/low free thyroxine) groups.
- Comparison of all-cause and cardiac mortality between the two groups over a median follow-up of 3.5 years.
Main Results:
- The hypothyroidism group (n=131) was older, had more females, and higher rates of atrial fibrillation, stroke, and renal dysfunction compared to the euthyroid group (n=1846).
- Elevated TSH was significantly associated with higher all-cause mortality (26.0% vs 11.7%, P < 0.0001) and cardiac mortality (9.2% vs 4.6%, P = 0.014).
- Multivariate analysis identified TSH elevation as a significant predictor of all-cause mortality (adjusted hazard ratio 1.560, P = 0.041).
Conclusions:
- Patients with acute myocardial infarction and elevated TSH exhibit worse clinical outcomes.
- TSH elevation independently predicts all-cause mortality in the AMI patient population.
- These findings underscore the importance of monitoring thyroid function in AMI patients for risk stratification.
Background:
Hypothyroidism has been known to be associated with hyperlipidemia, endothelial dysfunction and atherosclerosis. Elevation of thyroid-stimulation hormone (TSH) is a gold standard to detect these conditions. However, no large studies have investigated the association between TSH elevation and long-term clinical outcomes in patients with acute myocardial infarction (AMI).
Hypothesis:
Hypothyroidism is associated with higher mortality in patients with AMI.
Methods:
A total of 4748 AMI patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents were consecutively enrolled. We analyzed 1977 patients whose thyroid function data available after the exclusion of hyperthyroidism and possible central hypothyroidism. Patients were divided into two groups; euthyroid group (n = 1846) with normal TSH and normal free thyroxine (FT4); hypothyroidism group (n = 131) with elevated TSH and normal or low FT4. The two groups were subsequently compared with their all-cause and cardiac mortalities.
Results:
Median follow-up duration was 3.5 years. Hypothyroidism group were older, included in more females, and had higher incidences of atrial fibrillation, stroke, and renal dysfunction. Elevated TSH was associated with significantly higher all-cause mortality (26.0% vs 11.7%, P < 0.0001) and cardiac mortality (9.2% vs 4.6%, P = 0.014). The multivariate Cox proportional hazards model identified that TSH elevation was a significant predictor of all-cause mortality (adjusted hazard ratio 1.560, 95% confidence interval 1.017 to 2.392, P = 0.041).
Conclusions:
Our data suggest that AMI patients with TSH elevation had worse clinical outcome. Moreover, TSH elevation was a predictor of all-cause mortality in patients with AMI.
Related Concept Videos
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Types of Hormones
Hormonal Regulation
Hormonal Regulation
Plant Hormones

